2021
DOI: 10.1208/s12249-021-01980-5
|View full text |Cite
|
Sign up to set email alerts
|

Nanoparticulate tablet dosage form of lisofylline-linoleic acid conjugate for type 1 diabetes: in situ single-pass intestinal perfusion (SPIP) studies and pharmacokinetics in rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 48 publications
0
3
0
Order By: Relevance
“…The authors have cited additional references within the Supporting Information. [33][34][35][36][37][38][39][40][41][42]…”
Section: Supporting Informationmentioning
confidence: 99%
“…The authors have cited additional references within the Supporting Information. [33][34][35][36][37][38][39][40][41][42]…”
Section: Supporting Informationmentioning
confidence: 99%
“…41 After 48 h, 3-[4,5dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay was performed and the inhibition in cell growth was determined with respect to untreated cells (media only). 42 = × %cell viability absorbance absorbance 100 sample wells untreated wells (5) Once the cell compatibility was confirmed, freshly seeded MIN-6 cells (5000 cells/well) were further exposed to the above-mentioned mixture of proinflammatory cytokines to induce inflammation 43 followed by treatment with free LSF and synthesized LSF prodrugs (∼20 μM free LSF). After 48 h, cell viability was analyzed by MTT assay recording absorbance at 560 and 630 nm followed by calculating the % cell viability using eq 5.…”
Section: ■ Experimental Designmentioning
confidence: 99%
“…The cells incubated in growth media only served as the negative control, while the cells incubated with a cocktail of three different proinflammatory cytokines (TNF-α; 10 ng/mL, IL-1β; 5 ng/mL and IFN-γ; 100 ng/mL) served as the positive control . After 48 h, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay was performed and the inhibition in cell growth was determined with respect to untreated cells (media only) Once the cell compatibility was confirmed, freshly seeded MIN-6 cells (5000 cells/well) were further exposed to the above-mentioned mixture of proinflammatory cytokines to induce inflammation followed by treatment with free LSF and synthesized LSF prodrugs (∼20 μM free LSF).…”
Section: Experimental Designmentioning
confidence: 99%